Thanks to President Biden's leadership, drug manufacturers like Eli Lilly have followed suit and have voluntarily capped the price of insulin at $35 per month in the commercial market as well.
Carper highlights the impact of Biden's leadership on insulin pricing.
Share
More from Thomas R. Carper
We are better off when we hear community concerns at the beginning of the process rather than at the end.
Given how important this obviously is, my only regret is that we didn't have an opportunity to talk about it 24 hours ago.
Public engagement can build trust, it can increase public buy-in, can help resolve issues, can help prevent litigation, and ultimately it can save time and money.
I hope is that the issues we just discussed... we can keep at it today and see if we can't find a way to yes.